Hormonal
SIRT3 is a downstream target of PGC-1α and is essential for mediating the suppression of reactive oxygen species (ROS) and the stimulation of mitochondrial biogenesis in muscle cells.
This research highlights that SIRT3 is not just an isolated longevity gene but a key component of a larger system controlled by PGC-1α. To support mitochondrial health and reduce oxidative stress, interventions should focus on activating the upstream regulators (like PGC-1α) through exercise or metabolic stress, rather than just targeting SIRT3 in isolation.
Our results indicate that Sirt3 functions as a downstream target gene of PGC-1a and mediates the PGC-1a effects on cellular ROS production and mitochondrial biogenesis.
Why this rating
The study uses multiple robust in vitro methods (qPCR, Western blot, ChIP, EMSA, ROS assays) across multiple cell types (myotubes, hepatocytes), though it is preclinical.
Source
Sirtuin 3, a New Target of PGC-1α, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis
Xingxing Kong et al. · PLoS ONE · 2010
DOI 10.1371/journal.pone.0011707
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →